Menu
Search
|

Menu

Close
X

Merck & Co Inc MRK.N (New York Stock Exchange)

62.03 USD
-- (--)
As of Jun 15
chart
Previous Close 62.03
Open --
Volume --
3m Avg Volume 3,637,660
Today’s High --
Today’s Low --
52 Week High 66.41
52 Week Low 52.83
Shares Outstanding (mil) 2,690.30
Market Capitalization (mil) 166,879.50
Forward P/E 40.53
Dividend (Yield %) 0.48 ( 3.10 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.95 Mean rating from 20 analysts

KEY STATS

Revenue (mm, USD)
FY18
10,037
FY17
40,122
FY16
39,807
FY15
39,498
EPS (USD)
FY18
0.272
FY17
1.820
FY16
1.403
FY15
1.566
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
40.53
34.18
Price to Sales (TTM)
vs sector
4.10
8.57
Price to Book (MRQ)
vs sector
4.96
4.35
Price to Cash Flow (TTM)
vs sector
19.00
22.78
Total Debt to Equity (MRQ)
vs sector
69.97
17.37
LT Debt to Equity (MRQ)
vs sector
63.86
12.92
Return on Investment (TTM)
vs sector
5.78
13.17
Return on Equity (TTM)
vs sector
11.37
15.15

EXECUTIVE LEADERSHIP

Kenneth Frazier
Chairman of the Board, President, Chief Executive Officer, Since 2011
Salary: $1,572,210.00
Bonus: $2,686,580.00
Robert Davis
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $1,018,270.00
Bonus: $1,216,160.00
Mirian Graddick-Weir
Executive Vice President - Human Resources, Since 2009
Salary: --
Bonus: --
Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division, Since 2016
Salary: --
Bonus: --
Richard DeLuca
Executive Vice President, President - Merck Animal Health, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2000 Galloping Hill Rd
KENILWORTH   NJ   07033-1310

Phone: +1908.7404000

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

SPONSORED STORIES